These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

455 related items for PubMed ID: 17289084

  • 1. Effects of resveratrol on nerve functions, oxidative stress and DNA fragmentation in experimental diabetic neuropathy.
    Kumar A, Kaundal RK, Iyer S, Sharma SS.
    Life Sci; 2007 Mar 06; 80(13):1236-44. PubMed ID: 17289084
    [Abstract] [Full Text] [Related]

  • 2. Effects of U83836E on nerve functions, hyperalgesia and oxidative stress in experimental diabetic neuropathy.
    Sayyed SG, Kumar A, Sharma SS.
    Life Sci; 2006 Jul 17; 79(8):777-83. PubMed ID: 16581090
    [Abstract] [Full Text] [Related]

  • 3. Effects of trolox on nerve dysfunction, thermal hyperalgesia and oxidative stress in experimental diabetic neuropathy.
    Sharma SS, Sayyed SG.
    Clin Exp Pharmacol Physiol; 2006 Nov 17; 33(11):1022-8. PubMed ID: 17042909
    [Abstract] [Full Text] [Related]

  • 4. Preventive and curative effect of edaravone on nerve functions and oxidative stress in experimental diabetic neuropathy.
    Saini AK, Kumar H S A, Sharma SS.
    Eur J Pharmacol; 2007 Jul 30; 568(1-3):164-72. PubMed ID: 17521626
    [Abstract] [Full Text] [Related]

  • 5. Functional and biochemical evidence indicating beneficial effect of Melatonin and Nicotinamide alone and in combination in experimental diabetic neuropathy.
    Negi G, Kumar A, Kaundal RK, Gulati A, Sharma SS.
    Neuropharmacology; 2010 Mar 30; 58(3):585-92. PubMed ID: 20005237
    [Abstract] [Full Text] [Related]

  • 6. Neuroprotective potential of combination of resveratrol and 4-amino 1,8 naphthalimide in experimental diabetic neuropathy: focus on functional, sensorimotor and biochemical changes.
    Sharma SS, Kumar A, Arora M, Kaundal RK.
    Free Radic Res; 2009 Apr 30; 43(4):400-8. PubMed ID: 19291593
    [Abstract] [Full Text] [Related]

  • 7. N-acetylcysteine inhibits hyperglycemia-induced oxidative stress and apoptosis markers in diabetic neuropathy.
    Kamboj SS, Vasishta RK, Sandhir R.
    J Neurochem; 2010 Jan 30; 112(1):77-91. PubMed ID: 19840221
    [Abstract] [Full Text] [Related]

  • 8. Effects of adenosine and adenosine A2A receptor agonist on motor nerve conduction velocity and nerve blood flow in experimental diabetic neuropathy.
    Kumar S, Arun KH, Kaul CL, Sharma SS.
    Neurol Res; 2005 Jan 30; 27(1):60-6. PubMed ID: 15829161
    [Abstract] [Full Text] [Related]

  • 9. Chronic treatment of silymarin improves hyperalgesia and motor nerve conduction velocity in diabetic neuropathic rat.
    Baluchnejadmojarad T, Roghani M, Khastehkhodaie Z.
    Phytother Res; 2010 Aug 30; 24(8):1120-5. PubMed ID: 19960427
    [Abstract] [Full Text] [Related]

  • 10. Tanshinone IIA improves impaired nerve functions in experimental diabetic rats.
    Liu Y, Wang L, Li X, Lv C, Feng D, Luo Z.
    Biochem Biophys Res Commun; 2010 Aug 13; 399(1):49-54. PubMed ID: 20637731
    [Abstract] [Full Text] [Related]

  • 11. Emblica officinalis corrects functional, biochemical and molecular deficits in experimental diabetic neuropathy by targeting the oxido-nitrosative stress mediated inflammatory cascade.
    Tiwari V, Kuhad A, Chopra K.
    Phytother Res; 2011 Oct 13; 25(10):1527-36. PubMed ID: 21394805
    [Abstract] [Full Text] [Related]

  • 12. Concurrent targeting of nitrosative stress-PARP pathway corrects functional, behavioral and biochemical deficits in experimental diabetic neuropathy.
    Negi G, Kumar A, Sharma SS.
    Biochem Biophys Res Commun; 2010 Jan 01; 391(1):102-6. PubMed ID: 19900402
    [Abstract] [Full Text] [Related]

  • 13. Lipoic acid improves nerve blood flow, reduces oxidative stress, and improves distal nerve conduction in experimental diabetic neuropathy.
    Nagamatsu M, Nickander KK, Schmelzer JD, Raya A, Wittrock DA, Tritschler H, Low PA.
    Diabetes Care; 1995 Aug 01; 18(8):1160-7. PubMed ID: 7587852
    [Abstract] [Full Text] [Related]

  • 14. Neuroprotective effect of naringin by modulation of endogenous biomarkers in streptozotocin induced painful diabetic neuropathy.
    Kandhare AD, Raygude KS, Ghosh P, Ghule AE, Bodhankar SL.
    Fitoterapia; 2012 Jun 01; 83(4):650-9. PubMed ID: 22343014
    [Abstract] [Full Text] [Related]

  • 15. Effects of eugenol on nerve and vascular dysfunction in streptozotocin-diabetic rats.
    Nangle MR, Gibson TM, Cotter MA, Cameron NE.
    Planta Med; 2006 May 01; 72(6):494-500. PubMed ID: 16773532
    [Abstract] [Full Text] [Related]

  • 16. Melatonin modulates neuroinflammation and oxidative stress in experimental diabetic neuropathy: effects on NF-κB and Nrf2 cascades.
    Negi G, Kumar A, Sharma SS.
    J Pineal Res; 2011 Mar 01; 50(2):124-31. PubMed ID: 21062351
    [Abstract] [Full Text] [Related]

  • 17. Depletion of taurine in experimental diabetic neuropathy: implications for nerve metabolic, vascular, and functional deficits.
    Pop-Busui R, Sullivan KA, Van Huysen C, Bayer L, Cao X, Towns R, Stevens MJ.
    Exp Neurol; 2001 Apr 01; 168(2):259-72. PubMed ID: 11259114
    [Abstract] [Full Text] [Related]

  • 18. Morin exerts neuroprotection via attenuation of ROS induced oxidative damage and neuroinflammation in experimental diabetic neuropathy.
    Bachewal P, Gundu C, Yerra VG, Kalvala AK, Areti A, Kumar A.
    Biofactors; 2018 Mar 01; 44(2):109-122. PubMed ID: 29193444
    [Abstract] [Full Text] [Related]

  • 19. Protective effect of gliclazide on diabetic peripheral neuropathy through Drp-1 mediated-oxidative stress and apoptosis.
    Wu YB, Shi LL, Wu YJ, Xu WH, Wang L, Ren MS.
    Neurosci Lett; 2012 Aug 08; 523(1):45-9. PubMed ID: 22732450
    [Abstract] [Full Text] [Related]

  • 20. Oral supplementation of catalpol ameliorates diabetic encephalopathy in rats.
    Wang CF, Li DQ, Xue HY, Hu B.
    Brain Res; 2010 Jan 11; 1307():158-65. PubMed ID: 19852947
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.